What should you know about melanoma prognosis by age?

A prognosis is an estimate of how melanoma may behave and respond to treatment. Clinicians consider how deep the primary tumour is, whether it has ulceration, whether nearby lymph nodes or distant organs are involved, and whether treatment is controlling it. Age can affect other health conditions, medication choices, recovery, and the balance between treatment benefits and burdens. These factors explain why two people of the same age can have different outlooks, while people of different ages can share similar treatment pathways.

Ask the treating team to explain the confirmed stage and the pathology findings in plain language. Bring a list of medicines and health conditions, because these may affect surgery, immune-based treatment, scans, or recovery. Keep appointments for planned examinations and tests, and report new symptoms rather than waiting for the next routine visit. Follow-up after treatment helps clinicians look for recurrence and manage lasting effects. Prognosis is updated when new examination, pathology, imaging, or treatment-response information becomes available.

Contact the team promptly about a new lump near the treated area, a changing skin mark, unexplained bleeding, persistent pain, worsening breathlessness, new neurological symptoms, or a marked decline in daily function. During treatment, report fever, severe rash, diarrhoea, or other sudden changes because some therapies need rapid adjustment. Emergency help is appropriate for severe breathing difficulty, confusion, weakness on one side, or uncontrolled bleeding.

Ask which tumour features determine your outlook, what the stage means, and which uncertainties remain. Ask how your other health conditions affect treatment choices, which symptoms need same-day advice, and how follow-up will be organised. Request a written summary if medical terms are difficult to remember.